These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2903707)

  • 1. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-hydroxytryptamine receptor subtypes.
    Maura G; Bonanno G; Pittaluga A; Ulivi M; Raiteri M
    Ann Ist Super Sanita; 1988; 24(3):389-95. PubMed ID: 2903707
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
    Raiteri M; Maura G; Bonanno G; Pittaluga A
    J Pharmacol Exp Ther; 1986 May; 237(2):644-8. PubMed ID: 2871177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
    Maura G; Roccatagliata E; Ulivi M; Raiteri M
    Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of presynaptic 5-hydroxytryptamine1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices.
    Raiteri M; Maura G; Barzizza A
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1184-8. PubMed ID: 1675289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals.
    Maura G; Carbone R; Guido M; Pestarino M; Raiteri M
    Eur J Pharmacol; 1991 Sep; 202(2):185-90. PubMed ID: 1839384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
    Foy RA; Myles JL; Wilkerson RD
    J Pharmacol Exp Ther; 1992 May; 261(2):601-6. PubMed ID: 1533667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists.
    Kelly PA; Davis CJ; Goodwin GM
    Neuroscience; 1988 Jun; 25(3):907-15. PubMed ID: 2970017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic involvement in learning and memory.
    Hunter AJ
    Biochem Soc Trans; 1989 Feb; 17(1):79-81. PubMed ID: 2523830
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of a beta-adrenergic agonist on behaviors mediated by 5-HT1A and 5-HT1B receptors.
    Frances H; Simon P
    Biol Psychiatry; 1986 Sep; 21(11):1075-7. PubMed ID: 2943324
    [No Abstract]   [Full Text] [Related]  

  • 11. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.
    Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B
    J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of variation over 24-hours in response to stimulation of 5-HT1 receptors in the mouse brain.
    Moser PC; Redfern PH
    Chronobiol Int; 1985; 2(4):235-8. PubMed ID: 2966688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of serotonergic affect control.
    Kennett GA
    Adv Exp Med Biol; 1991; 294():231-43. PubMed ID: 1685293
    [No Abstract]   [Full Text] [Related]  

  • 17. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN; Fozard JR
    Eur J Pharmacol; 1983 May; 90(1):151-3. PubMed ID: 6223827
    [No Abstract]   [Full Text] [Related]  

  • 18. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
    Bobker DH; Williams JT
    J Pharmacol Exp Ther; 1989 Jul; 250(1):37-43. PubMed ID: 2526217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.